Since rWnt5a decreased the invasion of 22Rv1 and DU145 cells, invasion assay was also performed in these cell lines using Foxy5 which is a hexapeptide derived from the amino acid sequence of Wnt5a protein and previously shown to inhibit motility of breast cancer cells like rWnt5a [30]. The gene discussed is WNT5A; the disease is breast carcinoma.